Immunic market cap

WitrynaContact Email [email protected]. Phone Number +4989208047700. Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products; its lead development program, … Witryna1 dzień temu · Detailed statistics for Immunic, Inc. (IMUX) stock, including valuation metrics, financial numbers, share information and more. ... Immunic has a market …

Immunic Therapeutics - Funding, Financials, Valuation & Investors

WitrynaImmunic, cost to borrow history and number of IMUX shares available to borrow. companies: 7,324 total market cap: $87.045 T. Global ranking; Ranking by countries. … WitrynaImmunic started at outperform with $40 stock price target at BMO Capital Jul. 20, 2024 at 8:37 a.m. ET by Tomi Kilgore Immunic started at outperform with $59 stock price target at Wedbush fitted long winter coats for women https://cxautocores.com

Immunic Inc. (IMUX) Stock is expected to generate profits in the …

Witryna17 lis 2024 · November 17, 2024. NEW YORK, Nov. 17, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the formation of a Scientific-Medical … Witryna20 paź 2024 · The EIB and Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the signing of a €24.5 million financing agreement. The venture loan is intended to … WitrynaAs of March 2024 Immunic has a market cap of $70.15 Million . This makes Immunic the world's 6697th most valuable company by market cap according to our data. The … can i eat olives with gerd

Immunic, Inc. Announces Formation of Scientific-Medical …

Category:Immunic Therapeutics - PitchBook Data

Tags:Immunic market cap

Immunic market cap

Immunic Inc (IMUX) is down 5.26% Friday In Premarket Trading

WitrynaMarket Cap is a widely used stock evaluation measure. Find the latest Market Cap for Immunic (IMUX) WitrynaHistorical daily share price chart and data for Immunic since 2024 adjusted for splits. The latest closing stock price for Immunic as of February 27, 2024 is 1.89.. The all-time high Immunic stock closing price was 1332.40 on June 16, 2014.; The Immunic 52-week high stock price is 12.64, which is 568.8% above the current share price.; The …

Immunic market cap

Did you know?

Witryna20 mar 2024 · What is Immunic's Market Cap? ( NASDAQ: IMUX) Immunic 's market cap is $74.15M, as of Mar 22, 2024. Market cap (market capitalization) is the total … Witryna15 kwi 2024 · Aegis Capital bewertet die Aktie positiv mit einem Kauf-Rating. 22 März 2024 ... Veganer Markt. Rating nach Charttechnik. Überverkaufte Aktien. Überkaufte Aktien. Nahe am Widerstand. ... News auf Englisch zu IMMUNIC, INC. 13.03. Immunic, Inc. : Regulation FD Disclosure (form 8-K) AQ. 23.02. Immunic : Q4 2024 News …

Witryna15 kwi 2024 · The company has been renamed Immunic, Inc. and its common stock is expected to commence trading on The Nasdaq Capital Market under the ticker symbol "IMUX" on April 15, 2024. Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic … Witryna6 kwi 2024 · Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need – Conference Call and Webcast to be Held Today, February 9, 2024, at 11:00 am ET – NEW YORK , Feb. 9, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage …

WitrynaAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net Witryna31 mar 2024 · Immunic has a market cap or net worth of $66.16 million as of April 1, 2024. Its market cap has decreased by -79.28% in one year. Market Cap 66.16M. …

Witryna13 kwi 2024 · IMMUNIC, INC. : Veränderung des Consensus und Kursziel der Analysten der Aktie IMMUNIC, INC. IMUX US4525EP1011 Nasdaq

WitrynaProvides key financial indicators of Immunic (IMUX), including historical and latest data and analysis. You can query by quarterly, mid-term, and annual reports, and compare historical data easily. can i eat olives on candida dietWitryna1 dzień temu · Immunic Inc CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase... April 13, 2024 fitted long wool coatWitrynaMarket Cap-1M Daily Avg. Vol-3Y P/B Range - 52W Range - 3Y P/S Range - 3Y DivYield Range - Company Info. more arrow_right. Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerat... fitted lounge carpetsfitted long train wedding dressesWitryna7 kwi 2024 · MoneyLion Inc.’s market cap currently stands at around $133.26 million, with investors looking forward to this quarter’s earnings report slated for May 10, 2024 – May 15, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.06, which has seen fiscal year 2024 EPS growth forecast to increase to -$0.21 and about … fitted loveseat coversWitryna17 mar 2024 · See the latest Immunic Inc stock price (NASDAQ:IMUX), related news, valuation, dividends and more to help you make your investing decisions. ... IMUX’s market cap is 73.27 Mil. fitted low back sleeveless prom dressWitryna6 kwi 2024 · Immunic has caught the attention of market analysts with the release of positive data from the maintenance phase of its Phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC).. The company on Wednesday said data from the maintenance phase of … fitted lounge cupboards